Φορτώνει......
Liquid biopsies in lung cancer—time to implement research technologies in routine care?
Lung cancer is the leading cause of cancer mortality. A substantial progress in the understanding of lung cancer biology has resulted in several promising targeted therapies for advanced disease. Druggable targets today include point mutations such as EGFR, BRAF and re-arrangements in genes such as...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ann Transl Med |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5515804/ https://ncbi.nlm.nih.gov/pubmed/28758104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.04.12 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|